Freedman Edward D.
Insider CIK 1817434 · PAND Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PAND Pandion Therapeutics, Inc. | D To issuer deriv | 2021-04-01 | 2021-04-01 | 55,903 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | D To issuer deriv | 2021-04-01 | 2021-04-01 | 36,895 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | U Tender | 2021-04-01 | 2021-04-01 | 54,460 | $60.00 | $3.27M | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | A Award deriv | 2021-02-08 | 2021-02-10 | 36,895 | — | $0 | 36,895 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 11,974 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 2,348 | — | $0 | 54,461 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 2,112 | — | $0 | 2,112 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 53,131 | — | $0 | 53,131 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 660 | — | $0 | 660 | SEC↗ |